Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. An Advisory Committee Statement (ACS).
D000328:Adult; D000818:Animals; D002170:Canada / Q000453:epidemiology; D002417:Cattle; D002675:Child, Preschool; D005260:Female; D005759:Gastroenteritis / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007223:Infant; D008297:Male; D011247:Pregnancy; D012400:Rotavirus Infections / Q000453:epidemiology / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology; D014613:Vaccines, Attenuated
D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated